Frequently asked questions.

PVAC is a Federal Government initiative that brings together government, industry, and investors to expand local production of medicines and other health products, create jobs, and improve access to quality healthcare services in Nigeria.

PVAC focuses on enabling systemic change across the healthcare value chain by:

• Championing pro-manufacturing policies, reforms and incentives
• Facilitating partnerships for technology transfer across various innovations
• Co-creating financing mechanisms with development finance institutions (DFIs) and other partners

PVAC addresses critical gaps in Nigeria's healthcare ecosystem by driving measurable progress across three core areas:

• Limited local manufacturing capacity — increasing domestic production of health products and technologies (generics, vaccines, diagnostics, medical equipment, consumables) to reduce import dependence and strengthen national resilience.
• Insufficient job creation across the value chain — expanding quality jobs in the healthcare sector by unlocking foreign direct investment (FDI) and mobilising local capital.
• High reliance on outbound medical tourism — reducing the need for Nigerians to seek care abroad by improving the quality of healthcare services locally and catalysing alternative health ecosystems within the country.

PVAC works by:

• Identifying high-potential opportunities
• Structuring investment-ready initiatives
• Connecting stakeholders with financiers
• Supporting enabling policies and incentives

PVAC collaborates with a wide range of stakeholders, including:

• Government agencies
• Healthcare manufacturers
• Investors and DFIs
• Research and academic institutions
• Development organisations
• Private-sector players across the healthcare value chain

Organisations can engage PVAC through co-created initiatives, strategic partnerships, investment collaborations or ecosystem-development programs. Typically, all engagements are done in collaboration with at least one co-partner.

No. PVAC does not directly fund projects. Instead, it works with financing partners to design and enable access to funding mechanisms for viable healthcare initiatives.

Yes. PVAC supports startups and SMEs by connecting them with the right partners, investors and ecosystem opportunities — especially those aligned with healthcare manufacturing and innovation.

No. PVAC does not create or approve laws or policies. It plays an advocacy and advisory role by supporting reforms that enable local healthcare manufacturing and investment.

PVAC champions and supports policy reforms by:

• Engaging policymakers
• Providing industry insights and data
• Advocating for incentives that promote local production

PVAC does not:

• Mediate or arbitrate commercial disputes or agreements
• Manufacture or sell healthcare products or devices
• Execute programs without a co-partner
• Act as a regulatory or policy-approval body

No. PVAC does not intervene in or manage commercial negotiations or agreements between private entities.

No. PVAC does not produce, distribute or sell healthcare products. Its role is purely strategic and ecosystem-focused.

PVAC supports programs that:

• Strengthen local manufacturing capacity
• Enable healthcare innovation and R&D
• Improve access to financing
• Build ecosystem-wide collaboration

No. PVAC only undertakes initiatives in partnership with relevant stakeholders to ensure sustainability and shared ownership.

PVAC aims to:

• Increase local healthcare production in Nigeria
• Attract sustainable investments into the sector
• Strengthen the healthcare ecosystem
• Improve long-term healthcare outcomes

You can stay updated through PVAC's website, newsletters, events and stakeholder engagements.

Reach out via the contact page on the website for partnership and engagement opportunities.

PVAC operates across Nigeria, working with national and sub-national stakeholders to drive impact across the healthcare ecosystem.